 |
|
|
 |
|
Common Antioxidant Might Slow Parkinson's
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 As for natural sources of urate, they are mostly things that people are told to avoid for other reasons, Schwarzschild said -- fructose, the sugar often blamed for an epidemic of obesity; alcohol; and even smoking. "There is a lot of it in liver, but who wants to eat that much liver?" Shoulson added.
Parkinson's disease is a degenerative neurological illness in which deterioration of brain cells causes steadily worsening symptoms such as trembling and slowed motion. Indications that urate might affect the course of Parkinson's began to emerge from epidemiological studies decades ago, Schwarzschild said. More solid evidence came from a study reported last year, which led the researchers of the new study to look back at a two-decades-old study of 800 people with Parkinson's disease.
"They had donated spinal fluid as well as blood, so we were able to test for urate levels in spinal fluid, which surrounds the brain cells," Schwarzschild said.
Text Continues Below

Analysis showed that the one-fifth of participants with the highest urate levels had a 36 percent lower risk of disease progression compared to the one-fifth with the lowest levels.
"Urate is actually one of the major antioxidants that circulates in humans," Schwarzschild said. "Brain cell degeneration in Parkinson's, Alzheimer's disease or ALS [amyotrophic lateral sclerosis, Lou Gehrig's disease], is caused by oxidative damage."
But another expert agreed it's too early for dietary or treatment recommendations.
"This finding is very exciting, but not yet ready for applicability to individual patients," said Dr. Melissa Nirenberg, assistant professor of neurology and neuroscience at Weil Cornell Medical College in New York City, who was not involved in the study.
She said that the previous report had not generated many queries about urate from her patients. "This one may generate more buzz, but it is very, very concerning that uric acid is a risk factor for cardiovascular disease and other diseases," she said.
If she were asked about inosine, "I would never recommend it to a patient at this stage because we don't know whether it is cause-and-effect rather than just a relationship and whether the potential benefits outweigh the risks," Nirenberg said.
More information
There's more on Parkinson's disease and its treatment at the Parkinson's Disease Foundation.
Page: << Prev | 1 | 2
|
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 10/13/2009
|
 |

SOURCES: Michael A. Schwarzschild, M.D., Ph.D, associate professor, neurology, Harvard Medical School, director, MassGeneral Institute for Neurodegenerative Diseases, Boston; Ira Shoulson, M.D., professor, neurology, University of Rochester, N.Y.; Melissa Nirenberg, M.D., Ph.D., assistant professor, neurology and neuroscience, Weil Cornell Medical College in New York City; online Oct. 12, 2009, and December 2009 print edition of Archives of Neurology
|